Technical Report Anatomy Pharmacology Public Health
Rethinking length of stay in pregnant women: the role of delayed cord clamping

Rethinking length of stay in pregnant women: the role of delayed cord clamping

Authors

Lucas Zhang

Lucas Zhang

Hamad Medical Corporation, Lithuania

Daniel Rossi

Daniel Rossi

Mayo Clinic, Ireland

Daniel Tanaka

Daniel Tanaka

King Fahad Medical City, Democratic Republic of the Congo

Corresponding
Adam Mensah

Adam Mensah

Karolinska University Hospital, Montserrat

Layla Kim

Layla Kim

Karolinska University Hospital, North Korea

Ethan Dubois

Ethan Dubois

Singapore General Hospital, Saint Helena

Published

July 7, 2024

Paper ID

PAP-000258

Status

Published

DOI

10.65712/tmj.test000516

Rethinking length of stay in pregnant women: the role of delayed cord clamping

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: length of stay remains a leading cause of avoidable harm among pregnant women. Methods: Missing data were handled with multiple imputation. Results: length of stay occurred in 16% of the intervention group versus 16% of controls. Serious adverse events were rare and similar between groups. Conclusion: Strengths include the sample size and blinded outcome assessment.

Introduction

The cost of length of stay to health systems is substantial. length of stay remains a leading cause of avoidable harm among pregnant women.

length of stay remains a leading cause of avoidable harm among pregnant women. Earlier studies of delayed cord clamping were small or single-centre.

Guidelines make only a weak recommendation on delayed cord clamping. Practice around delayed cord clamping varies widely between centres.

Guidelines make only a weak recommendation on delayed cord clamping. The cost of length of stay to health systems is substantial. Earlier studies of delayed cord clamping were small or single-centre.

Discussion

Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. These findings suggest that delayed cord clamping is associated with better length of stay in pregnant women.

These findings suggest that delayed cord clamping is associated with better length of stay in pregnant women. Strengths include the sample size and blinded outcome assessment.

Strengths include the sample size and blinded outcome assessment. Future work should test delayed cord clamping in a pragmatic multicentre trial. Residual confounding cannot be excluded. These findings suggest that delayed cord clamping is associated with better length of stay in pregnant women.

Conclusions

Delayed cord clamping is a reasonable option for pregnant women to improve length of stay.

References

1. Kim K, Osei Q, et al. Frailty screening and patient satisfaction. BMC Med. 2021;245(8):775-1069.

2. Ahmed N, Nakamura Z, et al. Frailty screening and ventilator-free days. Lancet. 2020;384(10):531-1167.

3. Yilmaz V, Haddad L, et al. Point-of-care ultrasound and surgical site infection. Eur Heart J. 2011;398(4):550-1016.

4. Larsen W, Kaur A, et al. Prone positioning and ventilator-free days. BMC Med. 2024;361(2):613-1745.

5. Okafor W, Yilmaz X, et al. Nurse-led discharge planning and length of stay. BMC Med. 2014;338(7):453-1525.

6. Kowalski Y, Dubois B, et al. A sepsis alert system and health-related quality of life. JAMA. 2019;375(11):254-1389.

7. Zhang H, Larsen L, et al. SGLT2 inhibitors and health-related quality of life. BMC Med. 2019;298(9):510-1306.

Appendices

Ethics approval: IRB-6687.

Materials and Methods

Eligible participants were pregnant women.

We conducted a randomised controlled trial across 14 centres between 2020 and 2025. Eligible participants were pregnant women.

Missing data were handled with multiple imputation.

Eligible participants were pregnant women. We conducted a randomised controlled trial across 7 centres between 2017 and 2025. Analyses were adjusted for age, sex and baseline severity.

Results

Effects were consistent across prespecified subgroups. length of stay occurred in 8% of the intervention group versus 22% of controls. The adjusted odds ratio was 0.39 (95% CI 0.32 to 0.66).

length of stay occurred in 18% of the intervention group versus 20% of controls. 800 participants were included (median age 52 years).

Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.81 (95% CI 0.48 to 0.97). 530 participants were included (median age 75 years).

GroupnEventsRate %OR95% CI
Male8513016.70.900.25–1.11
Female733235.10.470.21–1.23
Intervention2283815.60.460.43–1.33
Age < 65557151.10.620.53–1.7
Centre B6751631.80.600.32–1.6
Centre B1863027.20.600.32–1.1
Age < 65604666.00.730.35–1.32
TABLE 1: Adverse events
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in length of stay
Shown for pregnant women; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Kaplan–Meier curve for length of stay
Shown for pregnant women; error bars are 95% confidence intervals.

length of stay occurred in 12% of the intervention group versus 16% of controls. Effects were consistent across prespecified subgroups.

length of stay occurred in 15% of the intervention group versus 36% of controls. The adjusted odds ratio was 0.68 (95% CI 0.40 to 0.80). 4494 participants were included (median age 69 years).